Colony »

Athira Pharma shares owned by Colony

Quarter-by-quarter ownership of Athira Pharma shares owned by Colony from 13F filings

Historical chart of Colony investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by Colony consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by Colony

Quarter filed Position value Share count Share price at filing
2025-09-30 $558k 8.4k 66.32

More positions owned by Colony

Select Sector Spdr Tr Technology (XLK)
Apple (AAPL)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Ea Series Trust Ea Bridgeway Omn (BSVO)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p Ttl Stk (ITOT)
Dimensional Etf Trust Us High Profitab (DUHP)

View all positions for Colony

Top funds holding Athira Pharma

Perceptive Advisors
BML Capital Management
Vanguard Group
Simplify Asset Management
Propel Bio Management
Tang Capital Management
Renaissance Technologies
Acadian Asset Management
Pathstone Holdings
BlackRock
Citadel Advisors
Geode Capital Management
Susquehanna International
Two Sigma Advisers
State Street Corporation

View all funds holding Athira Pharma